The Axonal Membrane Protein PRG2 Inhibits PTEN and Directs Growth to Branches
Annika Brosig,
Joachim Fuchs,
Fatih Ipek,
Cristina Kroon,
Sandra Schrötter,
Mayur Vadhvani,
Alexandra Polyzou,
Julia Ledderose,
Michiel van Diepen,
Hermann-Georg Holzhütter,
Thorsten Trimbuch,
Niclas Gimber,
Jan Schmoranzer,
Ivo Lieberam,
Christian Rosenmund,
Christian Spahn,
Patrick Scheerer,
Michal Szczepek,
George Leondaritis,
Britta J. Eickholt
Affiliations
Annika Brosig
Institute of Biochemistry, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
Joachim Fuchs
Institute of Biochemistry, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
Fatih Ipek
Institute of Biochemistry, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; Group Protein X-ray Crystallography and Signal Transduction, Institute of Medical Physics and Biophysics, Charité–Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
Cristina Kroon
Institute of Biochemistry, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
Sandra Schrötter
Institute of Biochemistry, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; Department of Genetics and Complex Diseases, T.H. Chan Harvard School of Public Health, Boston, MA 02120, USA
Mayur Vadhvani
Institute of Biochemistry, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
Alexandra Polyzou
Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece
Julia Ledderose
Institute of Biochemistry, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
Michiel van Diepen
Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa
Hermann-Georg Holzhütter
Institute of Biochemistry, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
Thorsten Trimbuch
Institute of Neurophysiology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
Centre for Stem Cells and Regenerative Medicine and Centre for Developmental Neurobiology, MRC Centre for Neurodevelopmental Disorders, King’s College, London, UK
Christian Rosenmund
NeuroCure-Cluster of Excellence, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; Institute of Neurophysiology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
Christian Spahn
NeuroCure-Cluster of Excellence, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; Institute of Medical Physics and Biophysics, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
Patrick Scheerer
Group Protein X-ray Crystallography and Signal Transduction, Institute of Medical Physics and Biophysics, Charité–Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
Michal Szczepek
Group Protein X-ray Crystallography and Signal Transduction, Institute of Medical Physics and Biophysics, Charité–Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
George Leondaritis
Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece; Corresponding author
Britta J. Eickholt
Institute of Biochemistry, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; NeuroCure-Cluster of Excellence, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; Corresponding author
Summary: In developing neurons, phosphoinositide 3-kinases (PI3Ks) control axon growth and branching by positively regulating PI3K/PI(3,4,5)P3, but how neurons are able to generate sufficient PI(3,4,5)P3 in the presence of high levels of the antagonizing phosphatase PTEN is difficult to reconcile. We find that normal axon morphogenesis involves homeostasis of elongation and branch growth controlled by accumulation of PI(3,4,5)P3 through PTEN inhibition. We identify a plasma membrane-localized protein-protein interaction of PTEN with plasticity-related gene 2 (PRG2). PRG2 stabilizes membrane PI(3,4,5)P3 by inhibiting PTEN and localizes in nanoclusters along axon membranes when neurons initiate their complex branching behavior. We demonstrate that PRG2 is both sufficient and necessary to account for the ability of neurons to generate axon filopodia and branches in dependence on PI3K/PI(3,4,5)P3 and PTEN. Our data indicate that PRG2 is part of a neuronal growth program that induces collateral branch growth in axons by conferring local inhibition of PTEN. : PTEN globally suppresses growth in multiple cell types and inhibits neuronal axon growth and branching. Brosig et al. describe a mechanism for developing neurons to inhibit PTEN function by upregulating PRG2 in the axon. Although the overall growth capacity of neurons remains constant, PRG2 redirects growth to axon branches. Keywords: PTEN, PI3K signaling, neuronal growth homeostasis, axon morphogenesis, phosphoinositide signaling, plasticity-related gene family, branching